Novartis, Adamis keep swinging at EpiPen with Symjepi pediatric dose
admin 28th September 2018 Uncategorised 0Novartis’ Sandoz is getting ready to stir things up in the epinephrine market—and as of Thursday, it has a green light to stir things up in the pediatric epinephrine market, too.
More: Novartis, Adamis keep swinging at EpiPen with Symjepi pediatric dose
Source: fierce